OPUS GENETICS INC. -
1,1100
29-ноября-24 13:45:00
15 мин. задержка
Акции
+0,0600
+5,71%
Сегодняшний диапазон
1,0500 - 1,1100
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Ocuphire Pharma to Present at the MicroCap Rodeo Windy City Roundup 2022 Conference
07 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Hosting Key Opinion Leader Event on Oral APX3330 for Diabetic Eye Disease
06 окт 2022 09:27:49 Источник Nasdaq GlobeNewswire
-
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
29 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
15 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol New Drug Application from FDA
12 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
08 сен 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at The H.C. Wainwright 24th Annual Global Investment Conference
06 сен 2022 09:00:01 Источник Nasdaq GlobeNewswire
-
12 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Upcoming Presentations at Two Conferences in August
08 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
03 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
07 июл 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
29 июн 2022 09:00:37 Источник Nasdaq GlobeNewswire
-
08 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
19 май 2022 07:00:00 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update
13 май 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
11 май 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
28 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Announces Upcoming Clinical Presentations at ARVO 2022 Medical Meeting and MODLive! 2022
26 апр 2022 09:00:02 Источник Nasdaq GlobeNewswire
-
19 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
Ocuphire Pharma to Present at Wet AMD & DME Drug Development Summit in Boston, MA
06 апр 2022 08:00:01 Источник Nasdaq GlobeNewswire